Orphenadrine Citrate Aspirin Caffeine
Product Images NDC 50564-554

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate Aspirin Caffeine (NDC 50564-554). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jerome Stevens Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (25 mg Bottle Label)

Packaging label for Orphenadrine Citrate Aspirin Caffeine tablets by Jerome Stevens Pharmaceuticals, Inc. The label indicates a package containing 100 tablets. It includes a caution that federal law prohibits dispensing without prescription and storage instructions to keep below 30°C (86°F). The label also features the NDC 50564-554-01 barcode and specifies active ingredients per tablet: Orphenadrine Citrate 25 mg, Aspirin 385 mg, and Caffeine 30 mg.*

FDA Label Image

Principal Display Panel (50 mg Bottle Label)

Label for Orphenadrine Citrate, Aspirin, Caffeine Forte tablets by Jerome Stevens Pharmaceuticals, Inc. It indicates a package of 100 tablets, listing the active ingredients with their amounts per tablet. The label includes storage instructions, a barcode, and federal dispensing caution. The label also states 'NO VARNISH' and 'KEEP OUT OF REACH OF CHILDREN.'*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.